Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial

被引：0
|
作者：
Soufila KT
Vishal Thakur
Tarun Narang
Sunil Dogra
Sanjeev Handa
机构：
[1] Postgraduate Institute of Medical Education and Research,Department of Dermatology, Venereology and Leprology
来源：
American Journal of Clinical Dermatology | 2021年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：415 / 423
页数：8
相关论文
共 50 条
  • [1] Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial
    Soufila, K. T.
    Thakur, Vishal
    Narang, Tarun
    Dogra, Sunil
    Handa, Sanjeev
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (03) : 415 - 423
  • [2] A randomized controlled trial to compare the efficacy and safety of apremilast and methotrexate in patients with palmoplantar psoriasis
    Soufila, K. T.
    Thakur, V.
    Narang, T.
    Dogra, S.
    Handa, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 : 9 - 9
  • [3] Comparative evaluation of efficacy and tolerability of apremilast and methotrexate in patients of moderate-to-severe palmoplantar psoriasis: A randomized, parallel, open-label clinical trial
    Wagh, Mitali
    Mukhi, Jayesh
    Sontakke, Smita
    Dhok, Amit
    Turankar, Avinash
    Kalikar, Mrunalini
    INDIAN JOURNAL OF PHARMACOLOGY, 2023, 55 (06) : 356 - 362
  • [4] Comparative efficacy of methotrexate versus apremilast for methotrexate-naive psoriasis patients: An indirect comparison
    Armstrong, April W.
    Betts, Keith
    Sundaram, Murali
    Thomason, Darren
    Signorovitch, James
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB229 - AB229
  • [5] Efficacy and safety of systemic methotrexate versus acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study
    Kanwar, A. J.
    Janagond, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 24 - 24
  • [6] Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study
    Janagond, A. B.
    Kanwar, A. J.
    Handa, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (03) : e384 - e389
  • [7] Comparison of the clinical efficacy of subcutaneous vs. oral administration of methotrexate in patients with psoriasis vulgaris: a randomized controlled trial
    Choonhakarn, Charoen
    Chaowattanapanit, Suteeraporn
    Julanon, Narachai
    Limpawattana, Panita
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (05) : 942 - 948
  • [8] The evaluation of efficacy and safety of methotrexate and pioglitazone in psoriasis patients: A randomized, open-labeled, active-controlled clinical trial
    Abidi, Afroz
    Rizvi, Dilshad Ali
    Saxena, Kshitij
    Chaudhary, Savita
    Ahmad, Ali
    INDIAN JOURNAL OF PHARMACOLOGY, 2020, 52 (01) : 16 - 22
  • [9] Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
    Papp, Kim
    Reich, Kristian
    Leonardi, Craig L.
    Kircik, Leon
    Chimenti, Sergio
    Langley, Richard G. B.
    Hu, ChiaChi
    Stevens, Randall M.
    Day, Robert M.
    Gordon, Kenneth B.
    Korman, Neil J.
    Griffiths, Christopher E. M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (01) : 37 - 49
  • [10] Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study
    Tadashi Terui
    Yukari Okubo
    Satomi Kobayashi
    Shigetoshi Sano
    Akimichi Morita
    Shinichi Imafuku
    Yayoi Tada
    Masatoshi Abe
    Masafumi Yaguchi
    Natsuka Uehara
    Takahiro Handa
    Masayuki Tanaka
    Wendy Zhang
    Maria Paris
    Masamoto Murakami
    American Journal of Clinical Dermatology, 2023, 24 : 837 - 847
12345